| Dr Bubu Banini, MD PHD | |
|
40 Temple St Ste 1a, New Haven, CT 06510-2715 | |
| (203) 688-4242 | |
| Not Available |
| Full Name | Dr Bubu Banini |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 15 Years |
| Location | 40 Temple St Ste 1a, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427320985 | NPI | - | NPPES |
| 66395 | Other | CT | CONNECTICUT PHYSICIAN LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
"The Health and Human Services department's 2009 quality report to Congress found 'very little progress' on eliminating hospital-acquired infections and called for 'urgent attention' to address the shortcomings — first brought to light a decade ago." Specifically, the report found that, for three out of the five major types of serious hospital-related infections, the rate of illness increased.
Mayo Medical Laboratories is introducing two comprehensive mobile applications for iPhones and iPads, allowing physicians and pathologists unparalleled access to clinical laboratory expertise from Mayo Clinic.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
The Centers for Medicare & Medicaid Services (CMS) has announced that it will host a public meeting to discuss development of standards for drug classes and categories under the new Medicare prescription drug benefit.
› Verified 9 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
"The Health and Human Services department's 2009 quality report to Congress found 'very little progress' on eliminating hospital-acquired infections and called for 'urgent attention' to address the shortcomings — first brought to light a decade ago." Specifically, the report found that, for three out of the five major types of serious hospital-related infections, the rate of illness increased.
Mayo Medical Laboratories is introducing two comprehensive mobile applications for iPhones and iPads, allowing physicians and pathologists unparalleled access to clinical laboratory expertise from Mayo Clinic.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
The Centers for Medicare & Medicaid Services (CMS) has announced that it will host a public meeting to discuss development of standards for drug classes and categories under the new Medicare prescription drug benefit.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bubu Banini, MD PHD 40 Temple St Ste 1a, New Haven, CT 06510-2715 Ph: () - | Dr Bubu Banini, MD PHD 40 Temple St Ste 1a, New Haven, CT 06510-2715 Ph: (203) 688-4242 |
News Archive
"The Health and Human Services department's 2009 quality report to Congress found 'very little progress' on eliminating hospital-acquired infections and called for 'urgent attention' to address the shortcomings — first brought to light a decade ago." Specifically, the report found that, for three out of the five major types of serious hospital-related infections, the rate of illness increased.
Mayo Medical Laboratories is introducing two comprehensive mobile applications for iPhones and iPads, allowing physicians and pathologists unparalleled access to clinical laboratory expertise from Mayo Clinic.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
The Centers for Medicare & Medicaid Services (CMS) has announced that it will host a public meeting to discuss development of standards for drug classes and categories under the new Medicare prescription drug benefit.
› Verified 9 days ago
Dr. Brian Christopher Cambi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St, Dcb 3, New Haven, CT 06510 Phone: 203-785-4129 Fax: 203-737-2437 | |
Ms. Maryam Gondal, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar Street, Bb 114, New Haven, CT 06510 Phone: 203-785-4184 | |
Matthew Joseph Mcconnell, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 333 Cedar St, Ynhh Internal Medicine-gi,section Of Digestive Diseases, New Haven, CT 06510 Phone: 203-785-7012 | |
Marie Anjeliese Rodriguez, Internal Medicine Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Margaret M Xu, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Carola Marte, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1450 Chapel St, Haelen Center, New Haven, CT 06511 Phone: 203-789-4135 Fax: 203-867-5241 | |
Jeanette M Tetrault, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 |